Jamesr Kasinger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jamesr kasinger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jamesr Kasinger Today - Breaking & Trending Today

CRISPR Therapeutics (NASDAQ:CRSP) Trading Up 1.1%

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shares shot up 1.1% on Thursday . The stock traded as high as $54.87 and last traded at $54.43. 183,713 shares were traded during mid-day trading, a decline of 89% from the average session volume of 1,686,077 shares. The stock had previously closed at $53.85. Wall Street […] ....

Samarth Kulkarni , Robertw Baird , Jamesr Kasinger , Headlands Technologies , Riggs Asset Managment Co , Bourgeon Capital Management , Cantor Fitzgerald , Blue Trust Inc , Wells Fargo Company , Securities Exchange Commission , Principal Securities Inc , Get Free Report , Stock Down , General Counsel James , Exchange Commission , Capital Management , Asset Managment , Principal Securities ,

CRISPR Therapeutics (NASDAQ:CRSP) Trading 1.1% Higher

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) rose 1.1% on Thursday . The company traded as high as $54.87 and last traded at $54.43. Approximately 183,713 shares changed hands during mid-day trading, a decline of 89% from the average daily volume of 1,686,077 shares. The stock had previously closed at $53.85. Analyst Upgrades and […] ....

Samarth Kulkarni , Jamesr Kasinger , Robertw Baird , Securities Exchange Commission , Principal Securities Inc , Bourgeon Capital Management , Headlands Technologies , Riggs Asset Managment Co , Blue Trust Inc , Needham Company , Wells Fargo Company , Get Free Report , General Counsel James , Exchange Commission , Capital Management , Asset Managment , Principal Securities ,

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 0%

Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 0% on Tuesday . The company traded as low as $54.55 and last traded at $55.22. 289,644 shares were traded during trading, a decline of 83% from the average session volume of 1,700,684 shares. The stock had previously closed at $55.24. Wall Street Analysts […] ....

United States , Jamesr Kasinger , Robertw Baird , Samarth Kulkarni , California Public Employees Retirement System , Morgan Stanley , Advisor Group , Securities Exchange Commission , Therapeutics Company Profile , Cantor Fitzgerald , Get Free Report , Exchange Commission , General Counsel James , Retirement System , Public Employees Retirement System , Arizona State Retirement System , State Retirement System ,

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 6%

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 6%
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Jamesr Kasinger , Samarth Kulkarni , Riggs Asset Managment Co , Blue Trust Inc , Needham Company , Securities Inc , Therapeutics Company Profile , Royal Bank , Bourgeon Capital Management , Principal Securities Inc , Get Free Report , General Counsel James , Asset Managment , Capital Management , Principal Securities ,

CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 0.9%

Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 0.9% during mid-day trading on Monday . The company traded as low as $55.25 and last traded at $55.74. 217,015 shares changed hands during trading, a decline of 87% from the average session volume of 1,733,235 shares. The stock had previously closed at $56.22. […] ....

Samarth Kulkarni , Jamesr Kasinger , Investment Management , Capital International Investors , Morgan Stanley , Needham Company , Royal Bank , Norges Bank , Avoro Capital Advisors , Therapeutics Company Profile , Securities Exchange Commission , Get Free Report , General Counsel James , Exchange Commission , International Investors ,